FastMed launches online weight program with GLP 1 medication
FastMed has launched a new online weight management programme offering prescription GLP-1 agonist drugs. The service follows strict safety checks to ensure patients receive genuine medication under medical supervision. Obesity, now classified by the World Health Organization as a chronic disease, remains a key focus of the initiative.
The programme operates through a three-step process designed to match in-clinic care standards. First, users complete an online health questionnaire. This is followed by a virtual consultation and a doctor’s evaluation to confirm suitability for GLP-1 treatment.
Once approved, patients receive a personalised treatment plan. FastMed then verifies the prescription before delivering the medication. The company emphasises that all drugs provided are authentic and prescribed only after a clinical assessment by a registered doctor. By offering a regulated online channel, FastMed aims to cut down on the circulation of counterfeit or non-compliant weight-loss drugs. The service provides an alternative for those seeking medical support without in-person visits.
The programme ensures access to prescription-only medication through a fully digital process. Patients must pass a clinical review before receiving treatment. FastMed’s approach aligns with WHO guidelines, which recognise obesity as a long-term health condition requiring proper medical management.
